Posts

Showing posts with the label drug pricing

China’s NRDL: The World’s Largest Market Access Event Is Underway

GLP-1s and the Rise of Consumer-Led Pharma: What the Obesity Market Signals for the Future of Access

Most-Favored-Nation Drug Pricing: Policy Shift or Pressure Tactic?

Trump’s Drug Pricing Executive Order: Uncertainty for Pharma Leaders

Tariffs on Pharmaceuticals: Are Drug Prices Set to Rise?

Breaking Barriers: TECELRA Becomes the First Engineered T-Cell Therapy for Solid Tumors

KISUNLA: Otro avance para los pacientes con enfermedad de Alzheimer

KISUNLA: Another breakthrough for Alzheimer’s Disease patients